Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950152-00-002532
Filing Date
2000-03-30
Accepted
2000-03-30 00:00:00
Documents
14
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 NEOPROBE CORPORATION 10-K405 10-K405 366896
2 EXHIBIT 10.2.52 EX-10.2.52 13972
3 EXHIBIT 10.4.40 EX-10.4.40 39642
4 EXHIBIT 10.4.41 EX-10.4.41 39938
5 EXHIBIT 10.4.42 EX-10.4.42 37596
6 EXHIBIT 10.4.43 EX-10.4.43 3992
7 EXHIBIT 10.4.44 EX-10.4.44 3990
8 EXHIBIT 11.1 EX-11.1 2300
9 EXHIBIT 21 EX-21 343
10 EXHIBIT 23.1 EX-23.1 860
11 EXHIBIT 23.2 EX-23.2 897
12 EXHIBIT 24.1 EX-24.1 16794
13 EXHIBIT 24.2 EX-24.2 2056
14 EXHIBIT 27 EX-27 2087
  Complete submission text file 0000950152-00-002532.txt   534047
Mailing Address 425 METRO PLACE NORTH SUITE 400 DUBLIN OH 43017
Business Address 425 METRO PLACE N STE 400 DUBLIN OH 43017 6147937500
NEOPROBE CORP (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-26520 | Film No.: 587026
SIC: 2835 In Vitro & In Vivo Diagnostic Substances